[儿科系统方法:对相互作用的复杂性进行上下文化]
Laurence Di Benedetto1, Pierre Ruffieux2, Charlotte Reith1
1Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|February 19, 2026
概括
一个病人一个病人.
科学领域:
- 家庭系统理论 家庭系统理论
- 医学社会学 医学社会学
- 医疗保健 心理学 心理学
背景情况:
- 患者的健康受到相互关联的家庭,社会和医疗系统的影响.
- 疾病,特别是在儿童中,严重破坏了既定的家庭动态和角色.
- 家庭,就像生物一样,通过寻求平衡和修改内部/外部相互作用来适应疾病.
研究的目的:
- 探索患者疾病对家庭系统的影响.
- 了解患者疾病期间家庭所经历的适应过程.
- 为医疗保健专业人员强调系统方法的有用性.
主要方法:
- 家庭互动和动态的定性分析.
- 观察家庭生命周期阶段 (危机,过渡,稳定).
- 系统理论的应用,以了解患者与系统的关系.
主要成果:
- 家庭系统与患者相互影响,影响整体健康结果.
- 疾病引发了一个动态的适应过程,角色的修改,并在家庭单位内恢复平衡.
- 护理人员观察到家庭适应疾病的不同阶段.
结论:
- 系统方法可以提高专业人员对患者与系统相互作用的理解.
- 在相互连接的系统中识别资源,需求和困难对于共同构建有效解决方案至关重要.
- 对系统方法的培训使专业人员能够更好地支持患者及其家人在疾病中.
相关概念视频
Pharmacokinetics in Pediatric Patients: Drug Metabolism
258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion
289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution
338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Factors Affecting Drug Response: Overview
3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Dosing: Infants and Children
344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344


